Neostigmine Methylsulfate Injection, Solution
Product Images NDC 76045-214
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 76045-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Neo0i 0004 02)
Figure 2 (Neo0i 0004 03)
Figure 3 (Neo0i 0004 04)
Fresenius Kabi Logo (Neo0i 0004 05)
Package Label (PRINCIPAL DISPLAY)
Package Label (PRINCIPAL DISPLAY)
Package Label (PRINCIPAL DISPLAY)
Package Label – Principal Display – Neostigmine 3 mL Syringe Label (Neo0i 0004 09)
Package Label – Principal Display – Neostigmine 3 mL Syringe Blister Label (Neo0i 0004 10)
Package Label – Principal Display – Neostigmine 3 mL Syringe Carton Label (Neo0i 0004 11)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.